Introduction
The coronavirus disease pandemic, the illness caused by severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) was first announced in an adult in China on 17 November 2019, and The World Health Organisation (WHO) inform the epidemic of SARS-CoV-2 as a Emergency of International Concern on January 30, 2020 (1,2).
There are rare data, particularly on infants and neonates with congenital heart disease (CHD) and children with CHD are considered to have a high risk to get COVID-19. Babies with CHD continue to be born at the rate of 1 in 100 live births during the pandemic, and approximately 25% of these are considered critical CHDs requiring surgery or other interventions in the first year of life. (3). History of cardiac surgery may be associated with the risk of hospitalization in the intensive care unit (ICU), intubation and mechanical ventilation, which is a more severe form of the disease in newborns and children (4).
In this report, we present the management of SARS-CoV-2 infection in the newborn after successful repair of aortic arch and ventricular septal defect (VSD) closure surgery. Although extracorporeal membrane oxygenation (ECMO) support was applied twice due to respiratory failure, the patient died due to multiorgan failure. To our knowledge, this patient was the first newborn to receive ECMO support for SARS-CoV-2 infection after congenital heart surgery. The consent was obtained from the family for the publication of this study.